Luminicell is a Singapore-based biotechnology company that specializes in advanced biocompatible fluorescent probes for long-term live cells, deep-tissue bio-imaging, and diagnostics applications with exceptional sensitivity.

 

Founded in 2014, Luminicell manufactures fluorescent lipid nanoparticles with its patented
encapsulation platform technology, combining it with novel Aggregation-Induced
Emission (AIE) molecular powering its next-generation, ultra-bright organic-based fluorescent nanoparticles.

 

Our flagship products exhibit outstanding photo-stability, enabling longitudinal studies and
continuous monitoring of biological processes to be performed, unlocking long-term imaging for both in vitro and in vivo applications. Our platform technology is highly tuneable, allowing users to achieve their unique application needs.